Comparative clinical efficacy of carvedilol and bisoprolol in the treatment of coronary heart disease within the patients with diabetes mellitus type 2
The article is devoted to the study of the clinical efficacy of the use of highly selective β- adrenoreceptor blocking agent of bisoprolol and β- adrenoreceptor blocking agent, which possesses additional vasodilating properties of carvedilol in the treatment of stable stenocardia within the patients with diabetes mellitus type 2. A comparative analysis of the effect of the studied medicines on the dynamics of heart strokes and the life quality of patients in the treatment process was carried out. It has been determined that bisoprolol and carvedilol have a comparable distinct antianginal effect, but carvedilol increases the physical component of life quality of the patients statistically more significant.